Citations

Mayo Clinic

Showing 10 of 108522 citations.

Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis
Vallejo, Bryan Alexis , Ansari, Ahmed , Achenbach, Sara J., Rabe, Kari G. , Norman, Aaron D. , Olson, Janet E. , Kay, Neil E. , Braggio, Esteban , Hanson, Curtis A. , Vachon, Celine M. , Baum, Cristian L., Shanafelt, Tait D. , Vallejo, Bryan A , Chaffee, Kari G. , Norman, Aaron D , Olson, Janet E , Kay, Neil E , Braggio, Esteban , Vachon, Celine M. , Cerhan, James R , Shanafelt, Tait D , Slager, Susan L , Parikh, Sameer A. , Cerhan, James R. , Slager, Susan L.

Journal of Clinical Oncology | September 4, 2024 | Volume: 42 | Issue: 35 | Pages: 4153-4162

10.1200/jco.24.00332 | PMID 39231386 Get It

PURPOSE Chronic lymphocytic leukemia (CLL)–phenotype monoclonal B-cell lymphocytosis (MBL) is a premalignant condition that is roughly 500-fold more common than CLL. It is unknown whether the two-fold increased risk of developing melanoma associated with CLL extends to individuals with MBL. METHODS Using the Mayo Clinic Biobank, we identified participants who were 40 years or older with no previous hematological malignancies, who resided in the 27 counties around Mayo Clinic, and who had available biospecimens for screening. Eight-color flow cytometry was used to screen for MBL. Individuals with MBL were classified as low-count MBL (LC-MBL) or high-count MBL on the basis of clonal B-cell percent. Incident melanomas were identified using International Classification of Diseases codes and confirmed via medical records review. Cox regression models were used to estimate hazard ratios (HRs) and 95% CI. RESULTS Of the 7,334 participants screened, 1,151 were identified with a CD5-positive MBL, of whom 1,098 had LC-MBL. After a median follow-up of 3.2 years (range, 0-13.5), 131 participants developed melanoma, of whom 36 individuals were positive for MBL. The estimated 5-year cumulative incidence of melanoma was 3.4% and 2.0% among those with and without MBL, respectively. After adjusting for age, sex, and history of previous melanoma, individuals with MBL exhibited a 1.86-fold (95% CI, 1.25 to 2.78) risk of melanoma. This elevated risk persisted when analysis was restricted to those without a history of melanoma (HR, 2.05 [95% CI, 1.30 to 3.23]). Individuals with LC-MBL had a 1.92-fold (95% CI, 1.29 to 2.87) increased risk of developing melanoma overall and a 2.74-fold increased risk (95% CI, 1.50 to 5.03) of melanoma in situ compared with those without MBL. CONCLUSION LC-MBL is associated with an approximately two-fold increased risk of melanoma overall and a 2.74-fold increased risk of melanoma in situ.
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue Sarcoma
Baldini, Elizabeth H. , Guadagnolo, B. Ashleigh , Salerno, Kilian , Miah, Aisha , Bedi, Meena , Harris, Jeremy P. , Petersen, Ivy A. , Gillham, Charles, Alektiar, Kaled M. , Kirsch, David G. , Petersen, Ivy, Chung, Peter W M , Bishop, Andrew Justin , Kalbasi, Anusha K. , Wiltink, Lisette M. , Haas, Rick L.

Journal of Clinical Oncology | September 4, 2024 | Volume: 42 | Issue: 36 | Pages: 4240-4245

10.1200/jco.24.00238 | PMID 39231372 Get It

Hypofractionated radiation therapy regimens should not be used as standard of care for localized soft tissue sarcoma
Increased Change in Cervical Lordosis Is Associated With Decreased Rate of Recovery in Patients With C5 Palsy
Frazzetta, Joseph, Pecoraro, Nathan C. , Jusué-Torres, Ignacio , Hofler, Ryan C. , Jones, G. Alexander, Nockels, Russ P., Jusue-Torres, Ignacio , Arnold, Paul M.

Clinical Spine Surgery | September 4, 2024 | Volume: 38 | Issue: 3 | Pages: E152-E159

10.1097/bsd.0000000000001680 | PMID 39226084 Get It

Study Design: A retrospective chart review. Objective: The authors aim to investigate the role of clinical and radiographic parameters in patients who underwent posterior cervical surgery, and their association with C5 palsy severity and time to recovery. Background: Postoperative C5 palsy affects 1%–30% of patients undergoing posterior decompression, with or without fusion. Causation and avoidance of this complication remain widely debated. Materials and Methods: A single institution review of patients who underwent posterior cervical spine surgery was focused on using specific Common Procedural Technology codes associated with the patient population of interest. Patients were excluded if they had inadequate pre and postoperative imaging, as well as a history of prior cervical spine surgery, concurrent anterior surgery, intradural pathology, spinal tumor, or spinal trauma. Radiographic measurements of the pre and postoperative images were completed with subsequent intraclass correlation coefficient analysis to confirm the precision of measurements. Results: Out of 105 total patients, 35 (33%) patients developed a C5 palsy. Twenty-four (69%) of those palsies completely resolved, with a median time to recovery of 8 months. Preoperative demographics and radiographic parameters demonstrated heterogeneity among those patients who did and did not have a resolution of palsy. Patients with increased change in C2–C7 lordosis (P = 0.011) after surgery were associated with decreased likelihood of recovery. Patients without a smoking history (P = 0.009) had an increased likelihood of recovering from C5 palsy. Conclusions: The degree of increased lordosis in the treatment of degenerative cervical disease plays a role in the rate of recovery from C5 palsy. This should be considered during preoperative planning in determining the amount of lordosis desired. In addition, patients without a smoking history were associated with a higher rate of recovery. Level of Evidence: Level IV.
A Call to Start Implementing the Results of High-Quality Randomized Trials in Daily Orthopaedic Practice
Ring, David , Crijns, Tom Joris

Journal of Bone and Joint Surgery | September 4, 2024 | Volume: 106 | Issue: 17 | Pages: e38

10.2106/jbjs.24.00491 | PMID 39230566 Get It

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary
Kasi, Pashtoon Murtaza , Ma, Li , Hart, Lowell L., Wong, Jenna , Spigel, David R. , Schnabel, Catherine A. , Reeves, James A. , Hálfdánarson, Þorvarður R. , Treuner, Kai , Greco, Frank A. , Fuentes, Harry E , Kasi, Pashtoon Murtaza , Spigel, David R , Halfdanarson, Thorvardur R , Treuner, Kai , Greco, F Anthony , Fuentes, Harry E , Wong, Jenna

JCO Precision Oncology | September 4, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/po.24.00191 | PMID 39231374 Get It

PURPOSE Cancer of unknown primary (CUP) is a syndrome comprising metastatic cancers without a clinically identified primary site. Although patients with CUP have an unfavorable prognosis, treatment with site-specific therapies guided by clinical features, standard pathology, and molecular assays can improve overall survival. The 92-gene assay (CancerTYPE ID) is a gene expression–based classifier that helps identify the tissue of origin for metastatic cancers with unknown or uncertain diagnoses. This study reports the frequency of selected molecular aberrations of oncogenes, including KRAS, IDH1/2, BRCA1/2, and BRAF, in patients with CUP in the MOSAIC database to highlight potential treatment options. METHODS MOSAIC is a database of patients with CUP submitted for CancerTYPE ID testing and NeoTYPE biomarker testing. Tumor biopsy samples were analyzed by CancerTYPE ID for tumor type identification and further tested for molecular aberrations of oncogenes, including KRAS, IDH1/2, BRCA1/2, and BRAF. RESULTS CancerTYPE ID identified a specific tumor type in 92.5% (2,929 of 3,168) of CUP cases in the MOSAIC database. The most commonly identified histological type was adenocarcinoma (75.4%), with pancreaticobiliary being the most common molecularly diagnosed cancer (24.9%). Aberrations in KRAS, IDH1/2, BRCA, and BRAF genes were identified in 18.8% (n = 597) of biopsies. A cancer-specific US Food and Drug Administration (FDA)–approved or investigational targeted therapy was potentially available for 24.6% (n = 147) of these patients. CONCLUSION This retrospective analysis supports incorporating CancerTYPE ID into the evaluation for patients with CUP to help determine the tissue of origin and identify actionable genetic alterations. This approach may allow more patients with CUP to benefit from site-specific FDA-approved targeted therapies or enrollment into clinical trials.
Mitigating the Risk of Instability After Reverse Shoulder Arthroplasty
Bindi, Victoria E. , Buchanan, Timothy R. , Cueto, Robert J. , Hones, Keegan M. , Wright, Thomas W. , King, Joseph J. , Hao, Kévin A. , Schoch, Bradley S , King, Joseph J , Hao, Kevin A , Hones, Keegan M , Schoch, Bradley S.

JBJS Reviews | September 4, 2024 | Volume: 12 | Issue: 9 | Pages: No page available

10.2106/jbjs.rvw.24.00095 | PMID 39226391 Get It

» Instability and dislocation after reverse shoulder arthroplasty may occur in up to 31% of patients. » Clinical risk factors for instability include younger age, male sex, increased body mass index, preoperative diagnosis of proximal humerus fracture or rotator cuff pathology, history of instability of the native shoulder or after surgery, and a medical history of Parkinson’s disease. » Patients with rheumatoid arthritis and decreased proximity to the coracoid may also be at greater risk. » In patients at a high risk of instability, surgeons should consider a more lateralized prosthesis (particularly in patients with an incompetent rotator cuff), repairing the subscapularis (particularly when using a medialized prosthesis), and upsizing the glenosphere (>40 mm in male and 38–40 mm in female patients). » While potentially useful, less evidence exists for the use of a constrained liner (particularly with a lateralized glenosphere and/or in low-demand patients) and rotating the polyethylene liner posteriorly to avoid impingement. Level of Evidence: Level V . Narrative Review. See Instructions for Authors for a complete description of levels of evidence.
Risk Factors for Inadequate Bowel Preparation in Colonoscopy: A Comprehensive Systematic Review and Meta-Analysis
Aboursheid, Tarek , Ali, Adel Hajj , Albunni, Hashem , Mohamed, Mouhand , Vargas, Alejandra , Hadaki, Nwal , Alsakarneh, Saqr , Rex, Douglas K., Guardiola, John , Aboursheid, Tarek , Mohamed, Mouhand F H , Vargas, Alejandra , Guardiola, John J , Albunni, Hashem N , Alsakarneh, Saqr G , Beran, Azizullah

American Journal of Gastroenterology | September 4, 2024 | Volume: 119 | Issue: 12 | Pages: 2389-2397

10.14309/ajg.0000000000003073 | PMID 39225554 Get It

INTRODUCTION: Inadequate bowel preparation (IBP) before colonoscopy remains a common problem. This meta-analysis aimed to assess the risk factors associated with IBP. METHODS: We searched multiple databases for studies that assessed risk factors for IBP after adjustment and reported the data as adjusted odds ratios with 95% confidence intervals. Meta-analyses were conducted using a random-effects model, and pooled adjusted odds ratios for risk factors reported in ≥ 3 studies were constructed. RESULTS: One hundred fifty-four studies with 358,257 participants were included. We analyzed 48 unique risk factors. Sociodemographic predictors of IBP were Medicaid insurance, obesity, current tobacco use, age ≥ 65 years, Black race, low education level, male sex, and unmarried status. Comorbidity-related predictors of IBP were any psychiatric disease, cirrhosis, American Society of Anesthesiologists (ASA) class ≥ 3, poor functional status, constipation, diabetes, previous abdominopelvic surgery, and hematochezia. Medication-related predictors of IBP were tricyclic antidepressants, antidepressants, opioids, nontricyclic antidepressants, and calcium channel blockers. Preparation/procedure-related predictors of IBP were brown liquid rectal effluent, any incomplete bowel preparation (BP) intake, lack of split-dose BP, increased BP-to-defecation interval, any nonadherence to dietary instructions, increased BP-to-colonoscopy interval, any BP intolerance, previous IBP, and inpatient status. Although afternoon colonoscopy was a predictor of IBP, subgroup analysis of prospective studies revealed no significant association. DISCUSSION: Our meta-analysis focused on adjusted risk factors to provide precise estimates of the most important risk factors for IBP. Our findings could help develop a validated prediction model to identify high-risk patients for IBP, improve colonoscopy outcomes, reduce the need for repeat colonoscopies, and reduce associated healthcare costs.
Integrating Human Factors to Enhance Healthcare Distance Simulation
Bailey, Shannon K. T. , Hughes, Ashley M. , Dong, Yue , Robertson, Jamie M. , Ray, Jessica M.

Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care | September 4, 2024 | Volume: 13 | Issue: 1 | Pages: 94-97

10.1177/2327857924131055 Get It

The Human Factors (HF) track at the Annual Healthcare Distance Simulation Summit focuses on improving the effectiveness of distance simulation utilizing human factors principles. During this presentation, we will 1. review the work to-date of the HF track of the Distance Simulation Summit, 2. discuss current opportunities for collaboration between human factors practitioners and simulationists, and 3. introduce ideas for future work. The potential target audiences for this discussion are researchers and practitioners who are interested in or involved in distance simulation or simulation in healthcare generally, educators who want to learn how to use distance simulation effectively and efficiently, and healthcare professionals and students who want to enhance their skills and knowledge about distance simulation. The presentation will stimulate discussion and feedback from the audience, which can enrich the knowledge base and generate new research questions and directions for distance simulation.
Long-term Outcomes of Partial Meniscectomy for Degenerative Medial Meniscus Posterior Root Tears
Lamba, Abhinav , Regan, Christina , Levy, Bruce A. , Stuart, Michael J. , Krych, Aaron J. , Hevesi, Mario , Krych, Aaron J , Stuart, Michael J , Lamba, Abhinav , Hevesi, Mario

Orthopaedic Journal of Sports Medicine | September 4, 2024 | Volume: 12 | Issue: 9 | Pages: No page available

10.1177/23259671241266593 | PMID 39247528 Get It

Background: Previous studies have demonstrated that medial meniscus posterior root tear (MMPRT) repair is superior to debridement in terms of patient-reported outcomes, rates of conversion to total knee arthroplasty (TKA), and long-term costs. Despite the known poor midterm outcomes, there is a paucity of long-term results of partial meniscectomy for degenerative MMPRTs. Purpose: To 1) evaluate long-term patient-reported and radiographic outcomes of patients who underwent partial medial meniscectomy (PMM) for MMPRTs, and 2) determine the rate of and risk factors for conversion to total knee TKA. Study Design: Case series; Level of evidence, 4. Methods: A previously identified cohort of 26 patients treated with partial meniscectomy for isolated MMPRTs between 2005 and 2013 was prospectively followed for long-term outcomes at a minimum 10-year follow-up. Patients were evaluated for International Knee Documentation Committee (IKDC) outcome score, reoperation, and conversion to TKA. Failure was defined as conversion to arthroplasty or a severely abnormal IKDC subjective score <75.4. Results: This study included 26 patients (10 men, 16 women; mean age, 54 ± 8.7 years [range, 38-71 years] at diagnosis; body mass index, 32.9 ± 5.5) who were followed for a mean of 14.0 ± 3.6 years (range, 10.1-19.6 years). At the final follow-up, 1 patient was deceased and 18 (72%) of the remaining 25 patients had progressed to TKA, with 1 (4%) patient undergoing repeat meniscectomy. The 6 (24%) patients who had not progressed to TKA or revision surgery reported a mean IKDC score of 57 ± 23. Nineteen patients underwent subsequent surgery and 5 demonstrated severely abnormal IKDC scores resulting in a clinical failure rate of 96% (24 of the 25 living patients) at a mean 14-year follow-up. Conclusion: PMM for medial meniscus posterior horn root tears demonstrated 72% progression to TKA and 96% failure according to subjective clinical outcomes at a minimum 10-year follow-up.
Localized tacrolimus therapy: innovations in peripheral nerve regeneration through advanced drug delivery systems
Millesi, Elena , Millesi, Flavia , Rechberger, Julian S. , Daniels, David J. , Radtke, Christine , Mardini, Samir

Therapeutic Delivery | September 4, 2024 | Volume: 15 | Issue: 10 | Pages: 743-748

10.1080/20415990.2024.2392481 | PMID 39229814 Get It